Ozanimod Could be an Alternative to Anti-TNF Drugs for Crohn's Disease

June 30, 2020


Ozanimod could soon be added to the ever growing stable of potential treatments for Crohn’s disease.

FDA Halts NASH Treatment Application

June 29, 2020


The FDA recommends additional safety and efficacy data from the ongoing REGENERATE trial.

C. Diff Infection Diagnosis Increases Risk for Family Members

June 28, 2020


Prior family exposure represented the factor with the second highest IRR behind hospital exposure.

Enhanced Treatment Endpoints Leads to Lower Risk of Ulcerative Colitis Relapse

June 24, 2020


The median 12-month risk of clinical relapse in patients with MES 1 was 28.7%, while the estimated annual risk of clinical relapse in patients with a MES 0 was 13.7%.

Upadacitinib Leads to Clinical Remission in Crohn's Disease

June 16, 2020


During the induction period, patients in the treatment group had higher incidences of infections and serious infectious compared to placebo.

Ildiko Lingvay, MD: Predictors of Gastrointestinal Events with Semaglutide

June 12, 2020


A recent analysis is examining potential factors associated with adverse gastrointestinal events in patients using semaglutide and whether it mitigates benefit.

Vibeke Strand, MD: Comorbidities Make Treating Psoriatic Arthritis Difficult

June 11, 2020


Dr. Vibeke Strand discusses how better treatment of psoriatic arthritis could yield better treatments for NASH.

NASH Indications Increasing Amongst Patients in Need of a Liver Transplant

June 10, 2020


Between 2002-2019, NASH is the leading liver indication for women without HCC.

AGA Releases New Guidelines for Probiotic Use in Gastroenterology

June 10, 2020


New recommendations support the use of probiotics for preterm and low birthweight infants to prevent mortality and necrotizing enterocolitis.

Dennis McGonagle, PhD: The Future of Guselkumab for Psoriatic Arthritis

June 08, 2020


Dr. Dennis McGonagle said guslekumab is also being tested in patients with inflammatory bowel disease.